NCT03070717 - High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV) | Biotech Hunter

Enrollment

153

Participants

Timeline

Start Date

June 12, 2014

Primary Completion Date

May 23, 2019

Study Completion Date

May 23, 2019

Conditions

Pathologic Myopia

Interventions

PROCEDURE

Observation & Diagnosis

SD-OCT, fundus autofluorescence, fundus photography, optional microperimetry, ophthalmic exams (BCVA, optical biometry), blood sampling.

Trial Locations (26)

10713

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

20246

Novartis Investigative Site, Hamburg

37075

Novartis Investigative Site, Göttingen

40225

Novartis Investigative Site, Düsseldorf

44892

Novartis Investigative Site, Bochum

45147

Novartis Investigative Site, Essen

48145

Novartis Investigative Site, Münster

48149

Novartis Investigative Site, Münster

49214

Novartis Investigative Site, Bad Rothenfelde

50924

Novartis Investigative Site, Cologne

53105

Novartis Investigative Site, Bonn

55131

Novartis Investigative Site, Mainz

60590

Novartis Investigative Site, Frankfurt

63768

Novartis Investigative Site, Hösbach

72076

Novartis Investigative Site, Tübingen

76133

Novartis Investigative Site, Karlsruhe

79106

Novartis Investigative Site, Freiburg im Breisgau

80637

Novartis Investigative Site, München

81377

Novartis Investigative Site, München

81675

Novartis Investigative Site, München

91522

Novartis Investigative Site, Ansbach

93053

Novartis Investigative Site, Regensburg

97080

Novartis Investigative Site, Würzburg

09113

Novartis Investigative Site, Chemnitz

04103

Novartis Investigative Site, Leipzig